MedPlus Health Services Limited has announced its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The company also reported the allotment of 19,095 equity shares under its Employee Stock Option Plan, 2021. The Board of Directors approved these results and the share allotment during their meeting held on October 27, 2026.
MedPlus Health Reports Q2 FY27 Financials
MedPlus Health Services Limited has released its unaudited consolidated financial results for the quarter and half-year period ending September 30, 2026. The results were approved by the Board of Directors during a meeting held on October 27, 2026. The company also presented the unaudited standalone and consolidated financial statements along with the Limited Review Reports from its statutory auditors.
Key Financial Highlights
For the quarter ended September 30, 2026, MedPlus Health reported Total Income of ₹20,576.51 million and Net Profit after Tax of ₹560.69 million. The consolidated figures for the half-year ended the same date showed Total Income at ₹39,570.77 million and Net Profit after Tax of ₹892.36 million.
Employee Stock Option Plan Allotment
In addition to the financial results, the Board also approved the allotment of 19,095 equity shares. These shares were issued under the MedPlus Employees Stock Option Plan, 2021 (ESOP, 2021), to eligible employees of the company and its group companies. Detailed disclosures related to this allotment, as required by SEBI regulations, will be provided separately.
Availability of Results
The financial results and related reports are now available on the company’s website, www.medplusindia.com, as well as on the websites of the BSE Limited (www.bseindia.com) and the National Stock Exchange of India Ltd. (www.nseindia.com).
Source: BSE
